US5284771A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Reagent compositions and their use in sphering cells
Assignee: Icahn School of Medicine at Mount Sinai
•
Filing: 1991-12-05
•
Granted: 1994-02-08
•
Expires: 2011-12-05
Abstract
Abstract Methods for blood sample preparation using reagent compositions which include a zwitterionic surfactant for sphering of cells to eliminate orientational noise. When the reagent composition including a for staining a subset of cells is reacted with an anticoagulated blood sample, and the reaction mixture is passed through the sensing region of a flow cytometer, the light scattered and absorbed by each cell is measured, the stained cells can be distinguished from the unstained cells, and when the cells are reticulocytes and mature erythrocytes, respectively, the volume and hemoglobin concentration of each reticulocyte or erythrocyte, and the hemoglobin content, mean cell volume, mean corpuscular hemoglobin concentration, and mean cell hemoglobin of the reticulocytes or erythrocytes are calculated from the measured cell-by-cell volume and hemoglobin concentration.
Inventors
- 👤 Sophie S. Fan
- 👤 Daniel Ben-David
- 👤 Albert Cupo
- 👤 Gena Fischer
- 👤 Grace E. Martin
- 👤 Leonard Ornstein
- 👤 Gregory M. Colella
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 22:06
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/5002; G01N15/00; G01N15/10; G01N15/14; G01N15/1456; G01N15/1459; G01N33/80; G01N33/96; G01N2015/1402; G01N2015/1477; Y; Y10; Y10T; Y10T436/00; Y10T436/10; Y10T436/101666; Y10T436/102499; Y10T436/107497; Y10T436/108331
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
88 words
A method for treating mammalian red blood cells in a whole blood sample which can be subsequently effectively measured electrooptically which comprises treating an inticoagulated whole blood sample with a single reagent solution containing a zwitterionic sphering agent to eliminate orientational noise when said sample and reagent are subject to flow cytometric light measurements which shpering agent does not include added protein buffering or fixative and which is present at a concentration which provides substantial sphering of the mature erythrocytes and the reticulocytes in said whole blood sample.
Claim 2
Independent Claim
88 words
A method for treating mammalian red blood cells in a whole blood sample which can be subsequently effectively measured electrooptically which comprises treating an inticoagulated whole blood sample with a single reagent solution containing a zwitterionic sphering agent to eliminate orientational noise when said sample and reagent are subject to flow cytometric light measurements which shpering agent does not include added protein buffering or fixative and which is present at a concentration which provides substantial sphering of the mature erythrocytes and the reticulocytes in said whole blood sample.
Claim 3
Dependent Claim
25 words
The method of claim 1 wherein the concentration of zeitterionic sphering agent in the diluted sample is from about 3.9 μg/ml to about 148 μg/ml.
Claim 4
Independent Claim
132 words
A method for identification of subclasses of cells of interest in an inticoagulated blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with a single aqueous agent composition consisting essentially of a zwitterionic sphering agent which does not include added protein buffering or fixative, and a non-proteinaceous neutral solute for adjusting the tonicity of the reagent to from about 0.5 to 2.0 times isotonic to form a suspension; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting and measuring the light scattered by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of the measured magnitude of said scattered light.
Claim 5
Independent Claim
132 words
A method for identification of subclasses of cells of interest in an inticoagulated blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with a single aqueous agent composition consisting essentially of a zwitterionic sphering agent which does not include added protein buffering or fixative, and a non-proteinaceous neutral solute for adjusting the tonicity of the reagent to from about 0.5 to 2.0 times isotonic to form a suspension; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting and measuring the light scattered by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of the measured magnitude of said scattered light.
Claim 6
Dependent Claim
64 words
The method of claim 3 wherein: step (a) includes adding a dye compound to selectively stain a subclass of interest; step (c) includes detecting and measuring the light scattered and light absorbed by each cell; and step (d) includes differentiating said cells of said subclass of interest at least in part on the basis of the measured magnitudes of said scattered and absorbed light.
Claim 7
Independent Claim
144 words
A method of identification of subclasses of cells of interest in an anticoagulated blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with an aqueos reagent composition to form a suspension, wherein the reagent composition consists essentially of a dye compound which stains the nucleic acids of cells, a non-proteinaceous pH buffer for maintaining a pH of about 6 to about 9, and a zwitterionic surfactant which does not include added protein buffering or fixative; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting and measuring the light scattered and light absorbed by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of the measured magnitudes of said scattered and absorbed light.
Claim 8
Independent Claim
144 words
A method of identification of subclasses of cells of interest in an anticoagulated blood sample by flow cytometry which comprises the steps of: (a) mixing an aliquot of said blood sample with an aqueos reagent composition to form a suspension, wherein the reagent composition consists essentially of a dye compound which stains the nucleic acids of cells, a non-proteinaceous pH buffer for maintaining a pH of about 6 to about 9, and a zwitterionic surfactant which does not include added protein buffering or fixative; (b) passing said suspension of step (a) substantially a cell at a time through an area of focused optical illumination; (c) detecting and measuring the light scattered and light absorbed by each cell; and (d) differentiating said cells of said subclass of interest at least in part on the basis of the measured magnitudes of said scattered and absorbed light.
Claim 9
Dependent Claim
33 words
The method of claim 5 wherein said dye compound described in step (a) is a cationic dye, and said total buffer concentration is isotonic to isovolumetrically sphere the cells in the blood sample.
Claim 10
Dependent Claim
26 words
The method of claim 5 wherein the surfactant of step (a) is selected from the group consisting of lauramidopropylbetaine, N-tetradecyl-N, N-dimethyl-3-ammonio-1-propanesulfonate, N-dodecyl-N, N-dimethyl-3-ammonio-1-propanesulfonate, cocoamidopropylbetaine and cocoamidosulfobetaine.
References Cited (Backward Citations)
US3684377A
Cited
US3883247A
Cited
GB2147999A
Cited
US4325706A
Cited
US4336029A
Cited
US4412004A
Cited
US4490353A
Cited
US4735504A
Cited
US4575490A
Cited
WO1985005640A1
Cited
US4652517A
Cited
US4985174A
Cited
US4707451A
Cited
US4883867A
Cited
US5039613A
Cited
US4971917A
Cited
US4981803A
Cited
US5075556A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1997-02-07 | 1997-08-09 | 1998-02-08 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2001-02-07 | 2001-08-09 | 2002-02-08 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2005-02-07 | 2005-08-09 | 2006-02-08 | $7700.00 | Window Closed / Lapsed |